
FRONTEO Inc.
CEO Masahiro Morimoto
2-12-23 Konan, Minato-ku, Tokyo
(Code No.: 2158 TSE Growth Market)
About FRONTEO: URL: https://www.fronteo.com/
FRONTEO is a data analysis company that specializes in using its proprietary AI engines, “KIBIT” and “Concept Encoder,” as well as “Looca Cross,” to extract significant and meaningful information from vast amounts of text data and intricate networks. These technologies support businesses by helping them draw meaningful insights from large and complex data. Since its inception in August 2003, the company has primarily focused on legal tech services such as e-discovery (electronic evidence disclosure) and digital forensic investigations to assist corporations with international litigation. In addition to the operations in Japan, the US, South Korea, and Taiwan, FRONTEO expanded its operations into life sciences, business intelligence, and economic security from 2014. Utilizing AI, the company has transformed textual data into actionable knowledge, aiding in drug discovery, dementia diagnosis, as well as finance, HR, and sales support. FRONTEO has made significant contributions to solving various corporate challenges. The company was listed on the TSE Mothers (now: TSE Growth Market) on June 26, 2007. In January 2021, they received a license for manufacturing and selling Class I medical devices (License No.: 13B1X10350) and reported the sales of these devices in September (Report No.: 3 Minato Life Devices No. 120). As of March 31, 2022, the company’s capital is 3,034,846 thousand yen.
*Note: FRONTEO, KIBIT, conceptencoder, and Looca Cross are registered trademarks of FRONTEO in Japan.<For Media Inquiries> FRONTEO Inc., Public Relations Email: pr_contact@fronteo.com
<For Inquiries related to Economic Security Business & AI Solutions> FRONTEO Inc., Economic Security Business Department https://osint.fronteo.com/contact/